| abstract |
The present invention can be used to diagnose a carcinoma or residual disease associated with a carcinoma, to observe the prognosis of a carcinoma, or to monitor the efficacy of an anti-tumor treatment against a carcinoma, or a carcinoma, in particular, colorectal carcinoma, carcinoma of the stomach, mammary carcinoma, The present invention relates to a method for monitoring for follow-up in a subject with lung carcinoma or carcinoma of the prostate, liver carcinoma, ovarian carcinoma, kidney carcinoma, thyroid carcinoma, bladder carcinoma or pancreatic carcinoma. The method of the present invention contacts adult hemo-derivative samples of an individual to be analyzed and validates the expression of at least one epithelial marker in stem cells by immunofluorescence, immunohistochemistry, ELISA or RT-PCR. It consists of doing |